Find clinical trials for Acute Myeloid Leukemia (AML) in Charlotte, NC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Acute Myeloid Leukemia (AML) trials near Charlotte, NC, USA:
The purpose of this study is to determine the recommended Phase 2 dose (RP2D) candidate(s) of JNJ-75276617 in combination with AML directed ...
Phase 1
Charlotte, North Carolina, United States and 29 other locations
PK of APG-2575 in combination with Azacitidine in the patients with AML/MPAL or MDS/CMML. The study consists of dose escalation (Part I) and...
Phase 1, Phase 2
Charlotte, North Carolina, United States and 8 other locations
This trial will seek to extend the preliminary findings of efficacy of MBG453 in combination with hypomethylating agents (HMA) by evaluating MBG453 i...
Phase 2
Charlotte, North Carolina, United States and 27 other locations
subjects with previously treated or untreated with high risk factor acute myeloid leukemia (AML). Venetoclax and ...
Phase 1
Charlotte, North Carolina, United States and 2 other locations
cytotoxic chemotherapy in induction-eligible patients with acute myeloid leukemia.This study involves the following:Veneto...
Phase 2
Charlotte, North Carolina, United States and 8 other locations
LAVA-051 in patients with relapsed or refractory Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), or Acute Myeloid...
Phase 1, Phase 2
Charlotte, North Carolina, United States and 13 other locations
or refractory (R/R) lymphomamultiple myelomanewly diagnosed acute myeloid leukemia (AML).This trial will be condu...
Phase 1
Charlotte, North Carolina, United States and 61 other locations
Some people with MDS have a risk of the disease progressing to acute myeloid leukemia (AML), and a risk of death ...
Phase 3
Charlotte, North Carolina, United States and 219 other locations
This is a phase I/II Study of Nivolumab in Combination with 5-azacytidine in pediatric patients with relapsed/refractory acute myeloid...
Phase 1, Phase 2
Charlotte, North Carolina, United States and 11 other locations
Tamibarotene is being studied as a treatment for participants with a type of leukemia called acute myeloid leukemia...
Phase 2
Charlotte, North Carolina, United States and 30 other locations
Clinical trials
Research sites
Resources
Legal